CytoTools AG announced that it has issued 1,109,498 common shares at an issue price of 3.95 per share for gross proceeds of 4,382,517.1 on May 19, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.406 EUR | 0.00% | -13.25% | -8.97% |
2023 | BioXXmed AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | BioXXmed AG Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
1st Jan change | Capi. | |
---|---|---|
-8.97% | 2.25M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- T5O Stock
- News bioXXmed AG
- CytoTools AG announced that it has received €4.382517 million in funding